{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:08:18Z","timestamp":1785186498924,"version":"3.55.0"},"reference-count":28,"publisher":"Hindawi Limited","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2674,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2008.01779.x","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T12:08:14Z","timestamp":1210075694000},"page":"1864-1869","source":"Crossref","is-referenced-by-count":74,"title":["Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia"],"prefix":"10.1155","volume":"62","author":[{"given":"F.","family":"Bogazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Buralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Raffaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Cigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Boresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Salvetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2008,5,6]]},"reference":[{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ncpendmet0160","article-title":"Drug insight: cabergoline and bromocriptine in the treatment of hyperprolactinemic men and women","volume":"2","author":"Colao","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/mds.20464","article-title":"Evidence-based medical review update: pharmacological and surgical treatment of Parkinson\u2019s disease: 2001 to 2004","volume":"20","author":"Goetz","year":"2005","journal-title":"Mov Disord"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1210\/jcem-69-4-725","article-title":"Effectiveness and tolerability of long-term treatment with cabergoline, a new long-lasting ergoline derivate, in hyperprolactinemic patients","volume":"69","author":"Ciccarelli","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1517\/13543784.11.6.787","article-title":"Dopamine receptor agonists for treating prolactinomas","volume":"11","author":"Colao","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0890-6238(02)00055-2","article-title":"Pregnancy outcome after cabergoline treatment in early weeks of gestation","volume":"16","author":"Ricci","year":"2002","journal-title":"Reprod Toxicol"},{"issue":"Suppl. A","key":"10.1111\/j.1742-1241.2008.01779.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S1096-6374(03)00054-6","article-title":"Pituitary tumors and pregnancy","volume":"13","author":"Molitch","year":"2003","journal-title":"Growth Hormone IGF-1 Res"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mds.20201","article-title":"Severe multivalvular heart disease: a new complication of the ergot derivative dopamine-agonist","volume":"19","author":"Horvath","year":"2004","journal-title":"Mov Disord"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00045415-200211000-00005","article-title":"Fibrotic valvular heart disease subsequent to bromocriptine treatment","volume":"10","author":"Serratrice","year":"2002","journal-title":"Cardiol Rev"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson\u2019s disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine agonists and the risk of cardiac-valve regurgitation","volume":"356","author":"Schade","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotoninergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"issue":"Suppl. 7","key":"10.1111\/j.1742-1241.2008.01779.x-BIB12|cit12","first-page":"39","article-title":"An evaluation of patients with hyperprolactinemia: have dynamic tests had their day?","volume":"26","author":"Di Sarno","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1056\/NEJMcp025334","article-title":"Clinical practice. Prolactinoma","volume":"349","author":"Schlechte","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ncpendmet0447","article-title":"Technology insight: measuring prolactin in clinical samples","volume":"3","author":"Smith","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB15|cit15","first-page":"1","article-title":"Dynamic testing in clinical endocrinology","volume":"26","author":"Moretti","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1530\/eje.1.02272","article-title":"Endocrine dysfunction inpatients operated on for non-pituitary intracranial tumors","volume":"155","author":"Schneider","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","article-title":"Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography","volume":"16","author":"Zoghbi","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11102-005-5083-4","article-title":"Prolactinomas and pregnancy","volume":"8","author":"Bronstein","year":"2005","journal-title":"Pituitary"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14656566.1.3.555","article-title":"Cabergoline","volume":"1","author":"Colao","year":"2000","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4065\/78.6.730","article-title":"The US food and Drugs Administration\u2019s registry of patients with pergolide-associated valvular heart disease","volume":"78","author":"Flowers","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1212\/01.WNL.0000083985.00343.F2","article-title":"Heart valvular disease in patients with Parkinson\u2019s disease treated with high-dose pergolide","volume":"61","author":"Van Camp","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(04)15945-X","article-title":"Treatment of Parkinson\u2019s disease with pergolide and relation to restrictive valvular heart disease","volume":"363","author":"Van Camp","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/01.WNL.0000129842.49926.07","article-title":"Pergolide use in Parkinson disease is associated with cardiac valve regurgitation","volume":"63","author":"Baseman","year":"2004","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1056\/NEJM200511033531822","article-title":"Cabergoline-related severe restrictive mitral regurgitation","volume":"353","author":"Pinero","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00415-007-0592-x","article-title":"Low incidence of restrictive valvulopathy in patients with Parkinson\u2019s disease on moderate dose of pergolide","volume":"254","author":"R\u016f\u017ei\u010dka","year":"2007","journal-title":"J Neurol"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/0002-8703(89)90739-4","article-title":"Prevalence of valvular regurgitation by Doppler echocardiography in patients with structurally normal hearts by two-dimensional echocardiography","volume":"117","author":"Choong","year":"1989","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0894-7317(14)80299-X","article-title":"Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers","volume":"3","author":"Klein","year":"1990","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1111\/j.1742-1241.2008.01779.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2008.01779.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2008.01779.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:07:44Z","timestamp":1643350064000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2008.01779.x"}},"subtitle":["Cabergoline, prolactin and heart"],"short-title":[],"issued":{"date-parts":[[2008,5,6]]},"references-count":28,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01779.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5,6]]}}}